Pfizer wins EU approval for $15 bln Hospira buy
August 04, 2015 at 11:36 AM EDT
BRUSSELS, Aug 4 (Reuters) - U.S. drugmaker Pfizer gained European Union antitrust approval on Tuesday for its proposed $15 billion acquisition of U.S. rival Hospira after pledging to sell some drugs to allay competition concerns.
